Search results
J&J (JNJ) Seeks Expanded Use of Tremfya for Crohn's Disease
Zacks via Yahoo Finance· 8 hours agoJ&J (JNJ) seeks label expansion for Tremfya for treating moderately to severely active Crohn's...
Johnson & Johnson (NYSE:JNJ) Shares Bought by Davis Capital Management
ETF DAILY NEWS· 1 day agoDavis Capital Management boosted its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 6.2% in the 1st quarter, according to its most recent filing with ...
Johnson & Johnson (JNJ) Stock Falls Amid Market Uptick: What Investors Need to Know
Zacks via Yahoo Finance· 3 days agoIn the latest market close, Johnson & Johnson (JNJ) reached $145.65, with a -0.21% movement compared...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks· 16 hours agoStocks recently featured in the blog include: Pfizer (PFE Quick QuotePFE - Free Report) , Johnson & Johnson (JNJ Quick QuoteJNJ - Free Report) and Eli Lilly and Co. (LLY Quick ...
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
Motley Fool via Yahoo Finance· 1 day agoIf you want decades of passive income, consider these two stocks to buy now and hold forever. Image...
Johnson & Johnson (NYSE:JNJ) Shares Sold by Smith Shellnut Wilson LLC ADV
ETF DAILY NEWS· 6 days agoSmith Shellnut Wilson LLC ADV decreased its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 5.6% in the fourth quarter, according to its most recent Form ...
Johnson & Johnson Insiders Sell US$4.8m Of Stock, Possibly Signalling Caution
Simply Wall St. via Yahoo Finance· 2 days agoIn the last year, many Johnson & Johnson (NYSE:JNJ) insiders sold a substantial stake in the company...
Johnson & Johnson submits application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the...
Morningstar· 1 day agoJohnson & Johnson (NYSE: JNJ) today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking ...
Johnson & Johnson seeks FDA nod for new cancer treatment By Investing.com
Investing.com· 4 days agoJohnson & Johnson (NYSE: JNJ) has submitted a Biologics License Application (BLA) to the U.S. Food...
Brown Shipley& Co Ltd Sells 1,579 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 4 days agoBrown Shipley& Co Ltd reduced its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 46.9% in the 4th quarter, according to the company in its most recent disclosure with ...